SMMT Company Profile and Key Details

Q: Who are the executives of SMMT?

Dr. Anne HeatheringtonHead of Clinical Devel. and Quantitative SciencesMr. Campbell HairHead of HR?Ms. Michelle AveryDirector of Investor RelationsMr. Will BlackHead of Information Technology?Mr. Robert W. DugganExecutive ChairmanDr. Mahkam Zanganeh D.D.S., M.B.A., MBAChief Executive Officer, Pres & DirectorMr. Ankur DhingraChief Financial OfficerDr. Urte Gayko Ph.D.Head of Regulatory Affairs, Quality Assurance & SafetyProf. Dame Kay Davies DBE, FRS CBECo-Founder, Chairman of Scientific Advisory Board and Scientific AdvisorDr. Elaine Carla Stracker J.D., Ph.D.Head of Compliance? & Gen. CounselMs. Shelley D. SprayHead of Corporation Education, Communications & Creative?Ms. Abby Guzman MurphyHead of HRMs. Divya ChariHead of Global Clinical OperationsMr. Dave GancarzSenior Vice President of Stakeholder Relations, Bus. Devel. & Corporation Strategy?

NASDAQ : SMMT

Summit Therapeutics

$17.54

0.26+1.50%

At Close 4:00 PM

69.53

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Summit Therapeutics Inc. (SMMT) stock surged +1.50%, trading at $17.54 on NASDAQ, up from the previous close of $17.28. The stock opened at $18.14, fluctuating between $17.24 and $18.32 in the recent session.

Stock Snapshot

17.28

Prev. Close

13.99B

Market Cap

17.24

Day Low

-15.66

P/E Ratio

-1.12

EPS (TTM)

-0.11

Cash Flow per Share

18.14

Open

797.75M

Number of Shares

18.3216

Day High

15.59%

Free Float in %

0.11

Book Value

4.75M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 09, 2026	18.20	18.32	17.24	17.54	4.73M
Sep 08, 2026	17.43	17.69	16.97	17.28	7.34M
Sep 04, 2026	16.93	17.63	16.80	17.61	6.22M
Sep 03, 2026	15.52	17.35	15.52	17.13	14.87M
Sep 02, 2026	14.15	14.72	14.06	14.60	3.65M
Sep 01, 2026	13.38	14.48	13.37	14.16	4.38M
Aug 31, 2026	13.51	13.73	13.44	13.62	5.42M
Aug 28, 2026	14.11	14.24	13.43	13.73	3.89M
Aug 27, 2026	14.30	14.65	13.92	14.33	4.79M
Aug 26, 2026	14.75	15.10	14.11	14.23	11.61M
Aug 25, 2026	13.27	13.60	13.05	13.36	6.26M
Aug 24, 2026	13.08	13.21	12.22	12.73	4.39M
Aug 21, 2026	12.69	13.53	12.57	13.16	7.07M
Aug 20, 2026	13.01	13.02	12.29	12.43	6.43M
Aug 19, 2026	13.31	13.39	12.92	13.11	5.42M
Aug 18, 2026	12.60	13.00	12.53	12.82	4.6M
Aug 17, 2026	13.05	13.07	12.07	12.78	9.87M
Aug 14, 2026	13.61	13.71	12.99	13.35	9.74M
Aug 13, 2026	15.16	15.24	13.99	14.00	6.52M
Aug 12, 2026	15.41	15.75	15.00	15.10	3.67M

Contact Details

Miami, FL 33131

United States

https://www.smmttx.com 617 514 7149

About Company

Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered small molecule antibiotic currently advancing through Phase III clinical trials as a treatment for CDI. Beyond its lead asset, Summit Therapeutics is also progressing SMT-738, designed to combat multidrug-resistant infections, notably carbapenem-resistant Enterobacteriaceae (CRE). Additionally, its DDS-04 series represents a potential therapeutic avenue for various infections caused by the Enterobacteriaceae family of bacteria. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.

Stock Peers

ARGX

-4.76-0.47%

argenx SE$1,002.31 REGN

-2.66-0.33%

Regeneron Pharmaceuticals, Inc.$807.65 MDGL

12.5+2.34%

Madrigal Pharmaceuticals, Inc.$546.66 VRTX

-7.78-1.47%

Vertex Pharmaceuticals Incorporated$521.12 UTHR

8.85+1.78%

United Therapeutics Corporation$506.82 ONC

-0.48-0.14%

BeOne Medicines AG$351.00 KRYS

-3.17-0.90%

Krystal Biotech, Inc.$348.09 PRAX

-7.18-2.04%

Praxis Precision Medicines, Inc.$345.30 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-0.78-0.27%

Ligand Pharmaceuticals Incorporated$288.05

Frequently Asked Questions

What is the current Summit Therapeutics Inc. (SMMT) stock price?

Summit Therapeutics Inc. (NASDAQ: SMMT) stock price is $17.54 in the last trading session. During the trading session, SMMT stock reached the peak price of $18.32 while $17.24 was the lowest point it dropped to. The percentage change in SMMT stock occurred in the recent session was 1.5% while the dollar amount for the price change in SMMT stock was $0.26.

SMMT's industry and sector of operation?

The NASDAQ listed SMMT is part of Biotechnology industry that operates in the broader Healthcare sector. Summit Therapeutics Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SMMT?

Dr. Anne Heatherington
Head of Clinical Devel. and Quantitative Sciences
Mr. Campbell Hair
Head of HR?
Ms. Michelle Avery
Director of Investor Relations
Mr. Will Black
Head of Information Technology?
Mr. Robert W. Duggan
Executive Chairman
Dr. Mahkam Zanganeh D.D.S., M.B.A., MBA
Chief Executive Officer, Pres & Director
Mr. Ankur Dhingra
Chief Financial Officer
Dr. Urte Gayko Ph.D.
Head of Regulatory Affairs, Quality Assurance & Safety
Prof. Dame Kay Davies DBE, FRS CBE
Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor
Dr. Elaine Carla Stracker J.D., Ph.D.
Head of Compliance? & Gen. Counsel
Ms. Shelley D. Spray
Head of Corporation Education, Communications & Creative?
Ms. Abby Guzman Murphy
Head of HR
Ms. Divya Chari
Head of Global Clinical Operations
Mr. Dave Gancarz
Senior Vice President of Stakeholder Relations, Bus. Devel. & Corporation Strategy?

How SMMT did perform over past 52-week?

SMMT's closing price is 45.32% higher than its 52-week low of $12.07 where as its distance from 52-week high of $29.23 is -39.99%.

How many employees does SMMT have?

Number of SMMT employees currently stands at 265.

Link for SMMT official website?

Official Website of SMMT is: https://www.smmttx.com

How do I contact SMMT?

SMMT could be contacted at phone 617 514 7149 and can also be accessed through its website. SMMT operates from 601 Brickell Key Drive, Miami, FL 33131, United States.

How many shares of SMMT are traded daily?

SMMT stock volume for the day was 4.75M shares. The average number of SMMT shares traded daily for last 3 months was 5.36M.

What is the market cap of SMMT currently?

The market value of SMMT currently stands at $13.99B with its latest stock price at $17.54 and 797.75M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	265
Beta	-1.24
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	265
Beta	-1.24
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

SMMT Company Profile and Key Details

Summit Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Dividend & Fair Value

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Shareholding & Insider Activity

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook